BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VEVENT DESCRIPTION:The Asthma and Allergy Foundation of America (AAFA)\, COPD Foun dation\, Global Allergy &\; Airways Patient Platform (GAAPP)\, and the Pulmonary Fibrosis Foundation (PFF) announce the Let’s Talk Cough initiati ve\, a groundbreaking joint effort to highlight the lived experience of ch ronic cough. This initiative aims to fully describe the impact of chronic cough on the lives of those affected across many conditions\, their curren t management strategies\, unmet medical needs\, and treatment benefits tha t matter most to them\, to inform the development of new therapies.On Octo ber 28\, 2026\, the Let’s Talk Cough initiative will culminate in a hybrid \, externally-led patient-focused drug development (EL-PFDD) meeting\, con ducted in parallel with the U.S. Food and Drug Administration’s (FDA) PFDD initiative. The meeting will be streamed live\, bringing members of the g lobal chronic cough community together to share their experiences and pers pectives. A “Voice of the Patient” report will summarize insights gathered during the Let’s Talk Cough meeting and throughout the planning process\, creating an invaluable resource for researchers\, life science companies\ , regulators\, healthcare professionals\, members of the chronic cough com munity\, and others. DTEND;VALUE=DATE:20261029 DTSTAMP:20260624T054620Z DTSTART;VALUE=DATE:20261028 LOCATION: SEQUENCE:0 SUMMARY:Let's Talk Cough UID:RFCALITEM639178587805950916 X-ALT-DESC;FMTTYPE=text/html:
The Asthma and Allergy Foundation of Amer ica (AAFA)\, COPD Foundation\, Global Allergy &\; Airways Patient Platf orm (GAAPP)\, and the Pulmonary Fibrosis Foundation (PFF) announce the Let ’s Talk Cough initiative\, a groundbreaking joint effort to highlight the lived experience of chronic cough. This initiative aims to fully describe the impact of chronic cough on the lives of those affected across many con ditions\, their current management strategies\, unmet medical needs\, and treatment benefits that matter most to them\, to inform the development of new therapies.

On October 28\, 2026\, the Let’s Talk Cough initiative will culminate in a hybrid\, externally-led patient- focused drug development (EL-PFDD) meeting\, conducted in parallel with th e U.S. Food and Drug Administration’s (FDA) PFDD initiative. The meeting w ill be streamed live\, bringing members of the global chronic cough commun ity together to share their experiences and perspectives. A “Voice of the Patient” report will summarize insights gathered during the Let’s Talk Cou gh meeting and throughout the planning process\, creating an invaluable re source for researchers\, life science companies\, regulators\, healthcare professionals\, members of the chronic cough community\, and others.
END:VEVENT END:VCALENDAR